Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis GlobeNewswire November 03, 2025 Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients […]

Nyxoah to Participate in the Stifel 2025 Healthcare Conference GlobeNewswire November 03, 2025 Nyxoah to Participate in the Stifel 2025 Healthcare Conference Mont-Saint-Guibert, Belgium – November 3, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that

James River Announces Third Quarter 2025 Results GlobeNewswire November 03, 2025 PEMBROKE, Bermuda, Nov. 03, 2025 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) reported a net loss from continuing operations available to common shareholders of $0.4 million, or ($0.01) per diluted share, compared to a net loss

Harmonic's cOS Virtualized Broadband Platform Will Further Enhance Broadband Experiences for Spectrum Customers Harmonic (NASDAQ: HLIT) today announced an expanded partnership with Spectrum to extend the company's industry-leading cOS™ vCMTS and advanced network and operational tools across Spectrum's entire service area, and include the deployment of DOCSIS 4.0 Unified Pebble-2 RPDs.The collaboration enables Spectrum to

NurExone Accepted into ARMI's BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing GlobeNewswire November 03, 2025 TORONTO and HAIFA, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company“) announced today that it has been accepted to the BioFab Startup Lab, part of the

(NasdaqGM:NVTS), Navitas 2.0 – strategic pivot to high-power markets with GaN and high-voltage SiC Key market focus on AI data center, performance computing, energy & grid infrastructure and industrial electrification Decisive actions and reallocation of resources to those high-growth, higher-margin markets TORRANCE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry

(NASDAQ:FLYE), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fly-E investors who were adversely affected by alleged securities fraud between July 15,

(NASDAQ:MRX), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Marex Group plc (“Marex Group plc” or the “Company”) (NASDAQ: MRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Marex Group plc investors who were adversely affected by alleged securities

Fly-E Group, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights – FLYE GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) of a class action

Navitas Semiconductor Announces Third Quarter 2025 Financial Results GlobeNewswire November 03, 2025 Navitas 2.0 – strategic pivot to high-power markets with GaN and high-voltage SiC Key market focus on AI data center, performance computing, energy & grid infrastructure and industrial electrification Decisive actions and reallocation of resources to those high-growth, higher-margin markets TORRANCE, Calif., Nov.